Legal Representation
Attorney
Christina M. Licursi
USPTO Deadlines
Next Deadline
172 days remaining
NOA E-Mailed - SOU Required
Due Date
July 14, 2026
Extension Available
Until January 14, 2027
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 9, 2026 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 8, 2026 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 8, 2026 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 8, 2026 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 22, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 22, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 22, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 22, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 22, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 27, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 27, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 14, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 27, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 11, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 13, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 13, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 22, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 22, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 22, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 8, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of human diseases and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for the treatment of physiological diseases; pharmaceutical products for cell therapy to treat human diseases and disorders, as well as aging; cell therapy products, namely, pharmaceutical preparations for cell therapy to treat human aging, diseases, and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for gene therapy to treat human diseases and disorders; pharmaceutical gene therapy preparations to treat human diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for gene and cell therapy
Class 042
Research and development in the field of pharmaceutical development; medical and scientific research and development in connection with cell aging and restoration; research and development of new products in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of gene therapy, genome writing, and genome engineering; scientific research and development in the field of pharmaceutical preparations for gene therapy; scientific research and development in the field of enzyme preparations for gene and cell therapy; research and development services in the field of genomics; medical and scientific research in the fields of genomics; providing medical and scientific research information in the fields of genomics; medical and scientific research in the field of genetics for the purpose of elevating single cell genome variants in order to identify transcription factors; scientific research and development and scientific research consulting, all in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics in relation to disease treatment and aging; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the field of genomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for medical and scientific research in the field of genomics; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with detecting variants in cells to treat disease and mitigate aging; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics for the purpose of disease treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with aging
Classification
International Classes
005
042